Vaccination with live vaccines, such as the live herpes zoster vaccine, is not recommended for people being treated with leflunomide, nor should a live vaccine be given sooner than a period of at least 6 months has elapsed after stopping leflunomide. Leflunomide has a long half‐life. There are no clinical data on the safety of vaccination with live vaccines during treatment with leflunomide.

DOI number

doi:10.1111/imj.14056

doi:10.1111/imj.14056

Menu category

Authors

Batty, K

Publication

Internal Medicine Journal 48(10): 1279-1280

Type of research

Journal article

Last updated: